Recent Finacing
Recent Raise
Cell BioEngines is a clinical-stage biotech that manufactures allogeneic, non-gene-modified umbilical cord blood–derived hematopoietic cell therapies at scale via a proprietary platform, advancing lead CBE-101 into multicenter clinical testing.
